Sunday, March 5

7:00 am – 3:00 pm

Registration Open

7:15 am – 8:30 am

Breakfast / Product Theater (Non-CE)

301

Case-based Learnings on a Treatment Approach for Certain Patients With High-Risk Non-muscle Invasive Bladder Cancer

Anne E. Calvaresi, NP

Sponsored by Merck

8:40 am – 9:40 am

General Session

302

Interstitial Cystitis: Understanding Bladder Pain Syndrome

1.0 CH

Erika Poderis, DNP, FNP-BC

The purpose of this presentation is to provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS), including discussion of treatments that should and should not be offered in the office setting by the advanced practice nurse.

9:50 am – 10:50 am

General Session

303

Advanced Interpretation of Urodynamic Tests

1.0 CH

Mikel Gray, RN, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN

This session will focus on advanced concepts related to interpretation of complex multichannel urodynamic testing, including pressure flow nomograms; calculation of bladder wall compliance; and assessment of urethral sphincter incompetence.

11:00 am – 12:00 pm

General Session

304

Transgender Health and Gender Affirming Surgery: Nursing Considerations

1.0 CH

Laura Douglass, MD

We will review transgender health and how to provide gender affirming care. We also will discuss gender affirming surgery and nursing care and considerations.

12:10 pm – 1:10 pm

CE Lunch Symposium

305

Metastatic Hormone-Sensitive Prostate Cancer: New Treatment Options

1.0 CH

Leanne Schimke, MSN, CRNP, CUNP, FNP-C

Sponsored by an unrestricted grant from Bayer HealthCare Pharmaceuticals Inc.

1:20 pm – 2:20 pm

General Session

306

Benign Urologic Conditions for the APP

1.0 CH

Adele Caruso, DNP, CRNP, FAANP

There are many common but benign urologic conditions. Among them are hematuria, urinary tract infections (UTIs), kidney stones, and kidney cysts. This presentation will encompass a discussion relative to the recognition and management of these conditions and specifically address the role of the urology advanced practice provider (APP).

2:30 pm – 3:30 pm

General Session

307

Neurogenic Bladder & Bowel: An Overview in Etiology, Diagnosis, and Treatment from Gestation to Gerontology

1.0 CH

Joy Kerr, DNP, CPNP-PC, CRNFA

Neurogenic bladder and neurogenic bowel occur in patients who have congenital anomalies, tumors/diseases of the central nervous system, spinal cord injuries, and stroke. We will review etiology, diagnosis, and treatments for both neurogenic bladder and bowel in these complex patients from gestation to gerontology.

< View the schedule for Saturday